These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 23927668)

  • 21. Experience of nasal application of inactivated influenza vaccine.
    Fukumi H
    Dev Biol Stand; 1976; 33():155-61. PubMed ID: 782963
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Universal influenza virus vaccines: need for clinical trials.
    Krammer F; Palese P
    Nat Immunol; 2014 Jan; 15(1):3-5. PubMed ID: 24352315
    [No Abstract]   [Full Text] [Related]  

  • 23. [Pandemic influenza vaccines: from the lab to ethical policy making].
    Grotto I; Levine H; Balicer RD
    Harefuah; 2009 Oct; 148(10):672-6, 735. PubMed ID: 20073393
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Influenza vaccination. The importance of antigen amount and adjuvant with reference to the humoral antibody formation after influenza vaccination. A comparative double-blind study with various vaccines].
    Sarateanu DE; Ehrengut W
    Fortschr Med; 1981 Sep; 99(34):1348-52. PubMed ID: 7026399
    [No Abstract]   [Full Text] [Related]  

  • 25. Influenza vaccine 2011-2012.
    Med Lett Drugs Ther; 2011 Oct; 53(1375):81-3. PubMed ID: 21996921
    [No Abstract]   [Full Text] [Related]  

  • 26. Influenza virus-like particle can accommodate multiple subtypes of hemagglutinin and protect from multiple influenza types and subtypes.
    Pushko P; Pearce MB; Ahmad A; Tretyakova I; Smith G; Belser JA; Tumpey TM
    Vaccine; 2011 Aug; 29(35):5911-8. PubMed ID: 21723354
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Influenza in the 1996/'97 season; vaccine composition for the 1997/'98 season].
    Rimmelzwaan GF; de Jong JC; Bartelds AI; Claas EC; van Wijngaarden JK; Osterhaus AD
    Ned Tijdschr Geneeskd; 1997 Sep; 141(36):1743-7. PubMed ID: 9545718
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antiviral drugs in influenza: an adjunct to vaccination in some situations.
    Prescrire Int; 2006 Feb; 15(81):21-30. PubMed ID: 16548114
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessment of the efficacy of influenza vaccines against natural challenge.
    Hobson D
    Dev Biol Stand; 1975; 28():285-94. PubMed ID: 1092575
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Trivalent intranasal influenza vaccine, live.
    McCarthy MW; Kockler DR
    Ann Pharmacother; 2004 Dec; 38(12):2086-93. PubMed ID: 15494383
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy and safety of influenza vaccines.
    Brenner E
    J S C Med Assoc; 2011 Jun; 107(3):78-82. PubMed ID: 22057708
    [No Abstract]   [Full Text] [Related]  

  • 32. Different influenza vaccine formulations and adjuvants for childhood influenza vaccination.
    Esposito S; Principi N
    Vaccine; 2011 Oct; 29(43):7535-41. PubMed ID: 21820478
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Five years experience with an influenza subunit vaccine (author's transl)].
    Majer M; Kindt H; Mettier B
    Immun Infekt; 1981 Nov; 9(6):232-8. PubMed ID: 7040211
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The use of inactivated influenza vaccine in children.
    Wright PF
    Semin Pediatr Infect Dis; 2006 Oct; 17(4):200-5. PubMed ID: 17055371
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Live attenuated influenza vaccine--a review.
    Gasparini R; Amicizia D; Lai PL; Panatto D
    J Prev Med Hyg; 2011 Sep; 52(3):95-101. PubMed ID: 22010534
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Live attenuated influenza vaccine in children.
    Ambrose CS; Walker RE; Connor EM
    Semin Pediatr Infect Dis; 2006 Oct; 17(4):206-12. PubMed ID: 17055372
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interim within-season estimate of the effectiveness of trivalent inactivated influenza vaccine--Marshfield, Wisconsin, 2007-08 influenza season.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2008 Apr; 57(15):393-8. PubMed ID: 18418344
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Strategies for successful rapid trials of influenza vaccine.
    Scheifele DW; Marty K; LaJeunesse C; Fan SY; Bjornson G; Langley JM; Halperin SA
    Clin Trials; 2011 Dec; 8(6):699-704. PubMed ID: 21900340
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy and safety of a live attenuated, cold-adapted influenza vaccine, trivalent against culture-confirmed influenza in young children in Asia.
    Tam JS; Capeding MR; Lum LC; Chotpitayasunondh T; Jiang Z; Huang LM; Lee BW; Qian Y; Samakoses R; Lolekha S; Rajamohanan KP; Narayanan SN; Kirubakaran C; Rappaport R; Razmpour A; Gruber WC; Forrest BD;
    Pediatr Infect Dis J; 2007 Jul; 26(7):619-28. PubMed ID: 17596805
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Influenza season 1998/99; composition of vaccine for 1999/2000].
    Rimmelzwaan GF; de Jong JC; Bartelds AI; Dorigo-Zetsma JW; Fouchier RA; Osterhaus AD
    Ned Tijdschr Geneeskd; 1999 Oct; 143(40):2015-8. PubMed ID: 10535060
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.